Navigation Links
Microfluidics International Corporation Announces Third Quarter 2009 Financial Results
Date:11/2/2009

NEWTON, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Microfluidics International Corporation (OTC Bulletin Board: MFLU), today reported unaudited financial results for the third quarter ended September 30, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090811/NE59652LOGO )

Third quarter accomplishments:

  • Earned net income for the third quarter of $425,000
  • Achieved $650,000 in earnings before interest, taxes, depreciation and amortization (EBITDA)
  • Delivered strong bookings in the third quarter of $4.8 million and a backlog of $4.75 million as of September 30, 2009
  • Generated $4.5 million in revenue for the third quarter, a 27% increase over the same period in 2008

"I am pleased to report that the strategic plan we implemented a year ago has led us to our first profitable quarter since my joining the Company," said Michael C. Ferrara, Chief Executive Officer of Microfluidics. "We will continue to innovate with new products, increase international representative and distributor coverage, streamline costs and improve quality in support of our customers as we strive to carry this positive momentum through the second half of the year and into 2010."

"The initiatives and strong cost controls implemented in the first half of the year are yielding tangible results," said Peter Byczko, Vice President of Finance and Chief Accounting Officer. "Demand in our product line remains strong, especially within our core biopharmaceutical markets and customers are exhibiting increased interest in value-added services as they realize the importance of maximizing machine uptime and availability. We are pleased with our results and will continue to work to improve the financial position of the Company."

Third Quarter Financial Results:

Revenues for the three months ended Septe
'/>"/>

SOURCE Microfluidics International Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2, 2009
2. Microfluidics International Corporation Announces Second Quarter 2009 Financial Results
3. Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009
4. Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization
5. Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
6. Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
7. GEN Reports on Growing Reliance on Microfluidics Technology
8. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
9. eBioscience Acquires Bender MedSystems; Business Combination Adds Cutting-Edge Product Lines and Expands International Operations
10. Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009
11. China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , iCardiac now provides ...utical companies. , Roche...nologies, Inc., a global leader in advanced cardia...ay that a top five pharmaceutical company has sele...b services. iCardiac will provide Highly Automate...
(Date:12/1/2009)... , Michael R. Drapp, a 34... formed nanoEdge™ Technologies, a business d...mpany focused on the emerging nanotechnology space...echnologies and act as a nanotechnology incubator....ecember 1, 2009 -- Michael R. Drapp , a 34-year v...
(Date:11/30/2009)... , , Cambridge, Mass November 30, 2009 An inter...Hamamatsu Photonics, and ETH Zrich have demonstrat... emitting in the invisible part of the light spect... single light beam of a well-defined wavelength. T...in applications related to remote chemical sensing...
(Date:11/30/2009)... , , BLOOMINGTON, Minn., Nov. 30 /PRNewsw...ormance medical image management software, data mi...cting with Allina Hospitals and Clinics for a new ...tion of image storage across the Allina network of...iving solution is based on the Acuo Technologies D...
Breaking Biology Technology:Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Scientists demonstrate multibeam, multi-functional lasers 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3
...Revenues Up 61%, Six-Month Net Revenues Up 40%, ET...arter and 67% for Six ...% for Second Quarter and 14% for Six ... Pharmaceutical Company,(NYSE: KVa/KVb) today repo...ng revenue and earnings growth for the second quar...
...Nov. 19 Beckman Coulter,Inc. (NYSE: BEC ), a lea...ucts that simplify, automate, and innovate complex...ynor, Beckman Coulter,s director of investor,relat...y Healthcare,Conference on Wednesday, November 28,...com.com/cgi-bin/prnh/20031202/BECLOGO ) The live ...
.... 19 Advanced Instruments, Inc., of,Norwood, Mass...0% of the,shares of Mart Microbiology B.V. of The ... disclosed. Mart Microbiology manufactures and ma...systems create custom environments for anaerobic,b...en-deprived atmospheres.,Typical applications incl...
Other Biology Technology:KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 2KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 3KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 4KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 5KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 6KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 7KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 8KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 9KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 10Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference 2Advanced Instruments Acquires Mart Microbiology B.V. 2
(Date:12/1/2009)... December 1, 2009: OptiNose is pleased to announce...ical study investigating the efficacy and tolerabi...for the topical treatment of chronic rhinosinusiti...ournal of the International and European Rhinologi...l polyps is a chronic disease that can significant...
(Date:12/1/2009)... This release is available in German . , Bro.... It contains loads of mitochondria, miniature po...at. In doing this, they normally generate a voltag...s energy for cellular processes. However, the mito...They go full steam ahead all the time. The energy ...
(Date:12/1/2009)... Yehezkel Ben-Ari, winner of the 2009 Inserm Grand...ed its commitment to paying tribute to outstanding...ts. By honouring talents, Inserm intends to,demon...lved in today,s biological, medical and,health re...and women who carry out and,drive this research e...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Wound Management Technologies Acquires Resorbable Orthopedics 5146 1Wound Management Technologies Acquires Resorbable Orthopedics 5146 2Wound Management Technologies Acquires Resorbable Orthopedics 5146 3Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 1Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 2Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 1Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 2Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 4
...ent has awarded five faculty planning grants to de... help solve the world,s urgent demands for fresh w... and well-being, yet in poor countries more than a...ies, and more than 2 billion lack basic sanitation...ichard Luthy, a professor of civil and environment...
...ther nature or nurture determines an ant,s status ...oth. , Nature (that is, the ant,s genetic makeup)...le in determining the fate of the Florida harveste...ound in many parts of the southeastern United Stat...the University of Illinois, the University of Ariz...
...dical Center immunologist and blood and marrow tra...e as the study co-chair for a new national clinica...rd blood transplants for severe sickle cell dise...ther medical institutions in the first-ever Phase ..., the Sickle Cell Unrelated Transplant (SCURT) tri...
Other Biology News:New planning grants to fund research on freshwater issues 2New planning grants to fund research on freshwater issues 3Genes and nutrition influence caste in unusual species of harvester ant 2Genes and nutrition influence caste in unusual species of harvester ant 3Children's national co-leads nationwide study of landmark sickle cell treatment 2
DTT 50 l from BD Biosciences Pharmingen
pRSET-E Echo Expression Vector Kit from Invitrogen
arrayWoRxe from Applied Precision, LLC
TopSpot E non-contact microarrayer from Parallabs
Biology Products: